Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition | Patent Number 07250419

US 07250419 B2
Application Number11230493
Publication NumberUS 20060025590 A1
Pendency1 year, 10 months, 13 days
Filled DateSep 21, 2005
Priority DateMar 8, 2000
Publication DateFeb 2, 2006
Expiration DateMar 8, 2020
Inventor/ApplicantsAnthony Ingall
Simon Guile
Paul Willis
David Hardern
Brian Springthorpe
ExaminesMOORE, SUSANNA
Art Unit1624
Technology Center1600
Assignments
Astrazeneca
Current
Astrazeneca
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.